Next Article in Journal
IBD Patients with Primary or Secondary Nonresponse to Ustekinumab Benefit from Dose Escalation or Reinduction
Next Article in Special Issue
Health-Related Quality of Life in Psoriasis: Literature Review
Previous Article in Journal
The Effect of Revascularization on Lower Limb Circulation Parameters in Symptomatic Peripheral Arterial Disease
Previous Article in Special Issue
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study
 
 
Article

Article Versions Notes

J. Clin. Med. 2024, 13(14), 3992; https://doi.org/10.3390/jcm13143992
Action Date Notes Link
article xml file uploaded 9 July 2024 06:17 CEST Original file -
article xml uploaded. 9 July 2024 06:17 CEST Update -
article pdf uploaded. 9 July 2024 06:17 CEST Version of Record -
article html file updated 9 July 2024 06:19 CEST Original file -
article xml file uploaded 9 July 2024 08:45 CEST Update -
article xml uploaded. 9 July 2024 08:45 CEST Update https://www.mdpi.com/2077-0383/13/14/3992/xml
article pdf uploaded. 9 July 2024 08:45 CEST Updated version of record https://www.mdpi.com/2077-0383/13/14/3992/pdf
article html file updated 9 July 2024 08:47 CEST Update https://www.mdpi.com/2077-0383/13/14/3992/html
Back to TopTop